OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
October 04, 2007
The rising influence of Asia in the global pharmaceutical ingredients market was evident at CPhI Worldwide.
Restructuring among contract manufacturing organizations and suppliers of pharmaceutical ingredients this year is bringing a new group of faces to CPhI Worldwide this year.
A roundup of news from exhibitors at CPhI Worldwide.
October 02, 2007
Orally disintegrating tablets (ODTs) continue to attract attention as an alternative to conventional oral dosage forms.
October 01, 2007
In 2007, the global pharmaceutical market is expected to grow moderately while biologics, generic drugs, and specialty-initiated drugs are projected to increase at double-digit rates. These trends for finished pharmaceuticals are reflected in the global market for APIs, where the merchant generic API market is expected to see strong demand. On a production basis, India and China are forecast to raise their shares of the global generic API market against industry strongholds Italy and Spain. Meanwhile, the US is expected to hold its its position as the leading producer of biotechnology-based APIs in an area traditionally dominated by captive production. And biogenerics or biosimilars gradually reshape the market.
September 26, 2007
The European Medicines Agency?s Committee for Medicinal Products for Human Use recommended the lifting of the suspension of the marketing authorization for ?Viracept? (nelfinavir mesylate) from Roche and the re-introduction of the drug in the European Union.